Pennant (PNTG) had the highest return between October 1, 2019 and December 30, 2019 by a small-cap US stock, returning 415.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Pennant (PNTG) | 10/1/2019 - 12/30/2019 | 415.28% |
Kodiak Sciences (KOD) | 10/1/2019 - 12/30/2019 | 411.2% |
Aurinia Pharmaceuticals (AUPH) | 10/1/2019 - 12/30/2019 | 276.91% |
Osisko Development (ODV) | 10/1/2019 - 12/30/2019 | 206.67% |
Fulcrum Therapeutics (FULC) | 10/1/2019 - 12/30/2019 | 168.46% |
Teekay Tankers (TNK) | 10/1/2019 - 12/30/2019 | 126.15% |
Xunlei Ltd Adr (XNET) | 10/1/2019 - 12/30/2019 | 124.78% |
Nordic American Tankers (NAT) | 10/1/2019 - 12/30/2019 | 124.21% |
DiaMedica Therapeutics (DMAC) | 10/1/2019 - 12/30/2019 | 122.79% |
Assembly Biosciences (ASMB) | 10/1/2019 - 12/30/2019 | 109.67% |
Prothena (PRTA) | 10/1/2019 - 12/30/2019 | 101.15% |
Rocket Pharmaceuticals (RCKT) | 10/1/2019 - 12/30/2019 | 98.97% |
Arvinas (ARVN) | 10/1/2019 - 12/30/2019 | 93.94% |
Castle Biosciences (CSTL) | 10/1/2019 - 12/30/2019 | 93.27% |
TSS, Inc Common Stock (TSSI) | 10/1/2019 - 12/30/2019 | 87.24% |
Savara (SVRA) | 10/1/2019 - 12/30/2019 | 85.98% |
Uniqure (QURE) | 10/1/2019 - 12/30/2019 | 83.9% |
Arbutus Biopharma (ABUS) | 10/1/2019 - 12/30/2019 | 82% |
Zymeworks Inc Common Stock (ZYME) | 10/1/2019 - 12/30/2019 | 80.34% |
InMode (INMD) | 10/1/2019 - 12/30/2019 | 79.75% |
Cidara Therapeutics (CDTX) | 10/1/2019 - 12/30/2019 | 76.77% |
Collegium Pharmaceutical (COLL) | 10/1/2019 - 12/30/2019 | 74.89% |
Avadel Pharmaceuticals (AVDL) | 10/1/2019 - 12/30/2019 | 74.46% |
Mama's Creations (MAMA) | 10/1/2019 - 12/30/2019 | 74.29% |
Borr Drilling (BORR) | 10/1/2019 - 12/30/2019 | 71.88% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
